Univ. Prof. Dr. Steffen Hering

E-mail: steffen.hering@univie.ac.at

University of Vienna
Dept. of Pharmacology and Toxicology
Althanstrasse 14
1090 Vienna

Researcher's Profile
Research interests:

  • Molecular Pharmacology of ion channels
  • Screening technologies
  • Subunit-dependent pharmacology of novel GABAA receptor ligands (in vitro, in vivo)

Personal Data:

Date of birth: 01.09.1954
Nationality: Germany


1973-1979 2nd Medical Institute, Moscow, Biophysics and Medicine
1983 Dissertation for the degree Doctor of Medicine ("doctor medicinae") at the Academy of Sciences Berlin
1983 Graduation: Specialist (medical) in physiology
1988 Habilitation: "doctor scientiae medicinae" [Dr. sc. med.]
1995 Habilitation (venia legendi) in Pharmacology and Toxicology at the University Innsbruck

Academic Positions:

1988-1989 Welcome Trust Research Fellow at St. George's Hospital, London, Department of Clinical and Experimental Pharmacology (Chairman: Prof. T.B. Bolton)
1990-1991 Research Assistant at the Max-Delbrück-Center for Molecular Medicine
August 1991 University Lecturer at the Institute for Biochemical Pharmacology University Innsbruck (Chairman: Prof. Glossmann)
1998 Assistent Professor at the Institute for Biochemical Pharmacology University Innsbruck (Chairman: Prof. Glossmann)
February 2003 Full Professor, Chairman of the Department of Pharmacology and Toxicology, University of Vienna

Ongoing MolTag Research projects as Supervisor:

Stanislav ANDRANOVITS: Probing the role of voltage sensors in calcium channel inactivation and inhibition by antagonists
Marco STADLER: Investigating a potentially synergistic anticonvulsant effect of dehydroabietic acid and derivatives

Completed MolTag Research projects:

Denise LUGER: Molecular determinants of anxiolytic and anticonvulsive properties of valerenic acid and derivatives; finished 11/2015
Daniela SCHÖFFMANN: Piperine Derivatives as New GABAA Receptor Ligands, finished 08/2015
Juliane HINTERSTEINER: In vivo Characterization of Natural Product GABAA Modulators and their Derivatives, finished 11/2015
Priyanka SAXENA: Probing the architecture of hERG potassium channel with drugs; finished 11/2015
Daria GOLDMANN: Selectivity Profiling of Ligands towards GABAA and TRPV1 Receptors, finished 09/2015